Literature DB >> 3541592

Development of hypogammaglobulinemia in a patient with systemic lupus erythematosus.

G C Tsokos, P L Smith, J E Balow.   

Abstract

This report describes a young girl in whom systemic lupus erythematosus (SLE) with normogammaglobulinemia but high serum DNA binding developed at age 10. She was subsequently treated with prednisone and intermittent cyclophosphamide for six years, and severe hypogammaglobulinemia associated with recurrent infections developed; disease remained active and serum DNA binding high. The possible contribution of treatment with cyclophosphamide to the development of hypogammaglobulinemia is discussed.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3541592     DOI: 10.1016/0002-9343(86)90413-4

Source DB:  PubMed          Journal:  Am J Med        ISSN: 0002-9343            Impact factor:   4.965


  5 in total

1.  Lupus vulgaris in a patient with systemic lupus erythematosus and persistent IgG deficiency.

Authors:  N Düzgün; M Duman; B Sonel; Y Peksari; C Erdem; G Tokgöz
Journal:  Rheumatol Int       Date:  1997       Impact factor: 2.631

2.  Cytokine profile in systemic lupus erythematosus, rheumatoid arthritis, and other rheumatic diseases.

Authors:  M al-Janadi; S al-Balla; A al-Dalaan; S Raziuddin
Journal:  J Clin Immunol       Date:  1993-01       Impact factor: 8.317

Review 3.  Differential Effects of MS Therapeutics on B Cells-Implications for Their Use and Failure in AQP4-Positive NMOSD Patients.

Authors:  Jan Traub; Silke Häusser-Kinzel; Martin S Weber
Journal:  Int J Mol Sci       Date:  2020-07-16       Impact factor: 5.923

4.  Association between lymphocyte subsets and cytomegalovirus infection status among patients with systemic lupus erythematosus: A pilot study.

Authors:  Ling Qin; Zhifeng Qiu; Evelyn Hsieh; Taoran Geng; Jiuliang Zhao; Xiaofeng Zeng; Lu Wan; Jing Xie; Rayoun Ramendra; Jean Pierre Routy; Taisheng Li
Journal:  Medicine (Baltimore)       Date:  2019-09       Impact factor: 1.817

5.  Pragmatic Treatment of Patients With Systemic Lupus Erythematosus With Rituximab: Long-Term Effects on Serum Immunoglobulins.

Authors:  Venkat Reddy; Lina Martinez; David A Isenberg; Maria J Leandro; Geraldine Cambridge
Journal:  Arthritis Care Res (Hoboken)       Date:  2017-04-24       Impact factor: 4.794

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.